340 related articles for article (PubMed ID: 19028034)
1. Recent advances in neurobiology of Tuberous Sclerosis Complex.
Napolioni V; Moavero R; Curatolo P
Brain Dev; 2009 Feb; 31(2):104-13. PubMed ID: 19028034
[TBL] [Abstract][Full Text] [Related]
2. The diverse clinical manifestations of tuberous sclerosis complex: a review.
Rosser T; Panigrahy A; McClintock W
Semin Pediatr Neurol; 2006 Mar; 13(1):27-36. PubMed ID: 16818173
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of a rapamycin analog (CCI-779) and IFN-gamma in tuberous sclerosis mouse models.
Lee L; Sudentas P; Donohue B; Asrican K; Worku A; Walker V; Sun Y; Schmidt K; Albert MS; El-Hashemite N; Lader AS; Onda H; Zhang H; Kwiatkowski DJ; Dabora SL
Genes Chromosomes Cancer; 2005 Mar; 42(3):213-27. PubMed ID: 15578690
[TBL] [Abstract][Full Text] [Related]
4. Combination of a rapamycin analog (CCI-779) and interferon-gamma is more effective than single agents in treating a mouse model of tuberous sclerosis complex.
Lee L; Sudentas P; Dabora SL
Genes Chromosomes Cancer; 2006 Oct; 45(10):933-44. PubMed ID: 16845661
[TBL] [Abstract][Full Text] [Related]
5. Tuberous sclerosis complex: linking growth and energy signaling pathways with human disease.
Astrinidis A; Henske EP
Oncogene; 2005 Nov; 24(50):7475-81. PubMed ID: 16288294
[TBL] [Abstract][Full Text] [Related]
6. Tuberous sclerosis complex and epilepsy: recent developments and future challenges.
Holmes GL; Stafstrom CE;
Epilepsia; 2007 Apr; 48(4):617-30. PubMed ID: 17386056
[TBL] [Abstract][Full Text] [Related]
7. Rapamycin as a therapy of choice after renal transplantation in a patient with tuberous sclerosis complex.
Tarasewicz A; Debska-Slizień A; Konopa J; Zdrojewski Z; Rutkowski B
Transplant Proc; 2009 Nov; 41(9):3677-82. PubMed ID: 19917366
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic targeting of mTOR in tuberous sclerosis.
Sampson JR
Biochem Soc Trans; 2009 Feb; 37(Pt 1):259-64. PubMed ID: 19143643
[TBL] [Abstract][Full Text] [Related]
9. The tuberous sclerosis complex proteins--a GRIPP on cognition and neurodevelopment.
de Vries PJ; Howe CJ
Trends Mol Med; 2007 Aug; 13(8):319-26. PubMed ID: 17632034
[TBL] [Abstract][Full Text] [Related]
10. The neurobiology of tuberous sclerosis complex.
Ess KC
Semin Pediatr Neurol; 2006 Mar; 13(1):37-42. PubMed ID: 16818174
[TBL] [Abstract][Full Text] [Related]
11. Behavioural and EEG effects of chronic rapamycin treatment in a mouse model of tuberous sclerosis complex.
Cambiaghi M; Cursi M; Magri L; Castoldi V; Comi G; Minicucci F; Galli R; Leocani L
Neuropharmacology; 2013 Apr; 67():1-7. PubMed ID: 23159330
[TBL] [Abstract][Full Text] [Related]
12. Molecular activity of sirolimus and its possible application in tuberous sclerosis treatment.
Jozwiak J; Jozwiak S; Oldak M
Med Res Rev; 2006 Mar; 26(2):160-80. PubMed ID: 16329102
[TBL] [Abstract][Full Text] [Related]
13. Management of epilepsy in tuberous sclerosis complex.
Curatolo P; D'Argenzio L; Cerminara C; Bombardieri R
Expert Rev Neurother; 2008 Mar; 8(3):457-67. PubMed ID: 18345974
[TBL] [Abstract][Full Text] [Related]
14. Enhanced episodic-like memory and kindling epilepsy in a rat model of tuberous sclerosis.
Waltereit R; Welzl H; Dichgans J; Lipp HP; Schmidt WJ; Weller M
J Neurochem; 2006 Jan; 96(2):407-13. PubMed ID: 16300636
[TBL] [Abstract][Full Text] [Related]
15. Evolving neurobiology of tuberous sclerosis complex.
Crino PB
Acta Neuropathol; 2013 Mar; 125(3):317-32. PubMed ID: 23386324
[TBL] [Abstract][Full Text] [Related]
16. Effects of rapamycin in the Eker rat model of tuberous sclerosis complex.
Kenerson H; Dundon TA; Yeung RS
Pediatr Res; 2005 Jan; 57(1):67-75. PubMed ID: 15557109
[TBL] [Abstract][Full Text] [Related]
17. Tuberous sclerosis complex: disease modifiers and treatments.
Au KS; Ward CH; Northrup H
Curr Opin Pediatr; 2008 Dec; 20(6):628-33. PubMed ID: 19005330
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of combined inhibition of mTOR and ERK/MAPK pathways in treating a tuberous sclerosis complex cell model.
Mi R; Ma J; Zhang D; Li L; Zhang H
J Genet Genomics; 2009 Jun; 36(6):355-61. PubMed ID: 19539245
[TBL] [Abstract][Full Text] [Related]
19. Regulation of neuronal morphology and function by the tumor suppressors Tsc1 and Tsc2.
Tavazoie SF; Alvarez VA; Ridenour DA; Kwiatkowski DJ; Sabatini BL
Nat Neurosci; 2005 Dec; 8(12):1727-34. PubMed ID: 16286931
[TBL] [Abstract][Full Text] [Related]
20. Tuberous sclerosis complex: advances in diagnosis, genetics, and management.
Schwartz RA; Fernández G; Kotulska K; Jóźwiak S
J Am Acad Dermatol; 2007 Aug; 57(2):189-202. PubMed ID: 17637444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]